Senseonics Receives European Approval for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
Drug Delivery Business

Glucotrack picks up new patents for continuous blood glucose monitor

Glucotrack (Nasdaq:GCTK) announced today that it received new U.S. patents for its continuous blood glucose monitoring (CBGM) ...
Drug Delivery Business

Senseonics wins CE mark for Eversense 365 year-long CGM

Senseonics (NYSE:SENS) announced today that its Eversense 365 continuous glucose monitor (CGM) system received CE mark ...